[Quick and short translation from a Belgium Newspaper by Jan van Roijen]
A brand-new test can mean an important breakthrough for treatment of
CFS and MS.
The biotechnological concern RED, in cooperation with an international
research-team, has succeeded in developing a test that makes it
possible to diagnose this chronic immune illness in a scientific
The blood test (a Yes/No test), don’t cost more than 25 euro. “This
test is an important step forward,” said professor Kenny De Meirleir.
“The later the diagnosis, the more irreversible damage is brought
about. We now know that CFS does harm to the thyroid glands after just
Worldwide millions of people are stricken by chronic immune diseases
and the number is rising. The first medicines will come on the market,
at the earliest, in three-five years.